Search
for
Sort by
Research 451–480 of 829
- A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.
- Familial 1q22 microduplication associated with psychiatric disorders, intellectual disability and late-onset autoimmune inflammatory response
- Disposition and metabolism of finasteride in dogs.
- Minoxidil
- Frontotemporal hairline recession in a postmenopausal woman
- A new in vitro culture system to produce a fully differentiated epidermis from human hair follicle outer root sheath cells
- Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients
- Regenerative Medicine to Reduce the Side Effects from Radiotherapy Causing Skin Cancer, Fibrosis, Neuropathic Pain and Hair Loss
- Kerion caused by Trichophyton tonsurans in an infant
- USE OF VALPROIC ACID FOR THE TREATMENT OF NEUROPSYCHIATRIC SYMPTOMS IN ACQUIRED BRAIN INJURIES
- Addressing the average lifespan of skin diseases is critical to good patient care
- Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
- Malabsorptive Disorders of Childhood
- Evaluation of a Porcine-Derived Placental Powder Treatment for Skin Wound Healing in an In Vivo Rat Skin Defect Model.
- Submission to the College of Physicians and Surgeons of Ontario. Re: Human Rights in the Provision of Health Services (2022)
- Hormone-related hair disorders - from clinical needs to new therapeutic perspectives
- A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer
- Androgenetic Alopecia: Pathogenesis, Evaluation, and Management
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Predstanormix Duo – a new domestic combination drug for the treatment of lower urinary tract dysfunction symptoms associated with BPH.
- Pericardial Disorders Occurring during Open Label Study of 3747 Patients Treated with Systemic Minoxidil
- 267 Single- and multiple-ascending dose studies of DS-2325a, a KLK5 inhibitor for the treatment of Netherton syndrome
- Integrated edge information and pathway topology for drug-disease associations
- Evaluation of skin disease patterns in a tertiary dermatology outpatient clinic in Türkiye
- 923 Molecular phenotyping of lichen planopilaris revealed dysregulation of cholesterol/fatty acid metabolism, fibrosis and mast cell pathways
- Pilot study: genetic distribution of AR, FGF5, SULT1A1 and CYP3A5 polymorphisms in male Mexican population with androgenetic alopecia.
- Androgenetic alopecia in women. Trichoscopy as a diagnostic method to simplify the proper diagnosis — case report
- EtG Quantification in Hair and Different Reference Cut-Offs in Relation to Various Pathologies: A Scoping Review